首页 | 本学科首页   官方微博 | 高级检索  
     

水飞蓟宾对抗大鼠酒精性脂肪肝作用及机制
引用本文:谭海荣,吴谦,潘竞锵,肖柳英,韩超,林洁茹,郑琳颖,李博萍. 水飞蓟宾对抗大鼠酒精性脂肪肝作用及机制[J]. 金属学报, 2004, 9(7): 803-806
作者姓名:谭海荣  吴谦  潘竞锵  肖柳英  韩超  林洁茹  郑琳颖  李博萍
作者单位:广州市中医中药研究所, 广州510130, 广东;1.广东省药物研究所, 广州510180, 广东;2.广州市中医医院, 广州510130, 广东
基金项目:广东省中医药局滚动资助项目(№302003);广州市中医药、中西医结合课题资助项目(№200237)
摘    要:目的: 观察水飞蓟宾(Silbinin)对大鼠酒精性脂肪肝作用及其机制。方法: 饮用10 %乙醇,加高脂高热量饲料喂饲6 周,造成大鼠酒精性脂肪肝模型;灌胃给药水飞蓟宾100mg·kg-1,继续酒精和高脂高热量饲料处理4 周后,处死大鼠,测定血清天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、碱性磷酸酶(AKP)活性和甘油三酯(TG)、胆固醇(TC)、低密度脂蛋白-胆固醇(LDL-C)、高密度脂蛋白-胆固醇(HDL-C)、大鼠肿瘤坏死因子-α(TNF-α)、大鼠转化生长因子-β1(TGF-β1)含量,测定肝细胞TG、肝匀浆丙二醛(MDA)、超氧化歧化酶(SOD)、还原性谷胱甘肽(GSH)水平以及肝组织学检查。结果: 水飞蓟宾能抑制病鼠血清AST、ALT、AKP活性(P<0.05或0.01)和降低TG、LDL-C、TNF-α、TGF-β1 含量(P<0.05或0.01),提高HDL-C 含量;降低肝匀浆TG 和MDA 含量(P<0.05或0.01),增强SOD 活性(P<0.01)以及改善肝细胞水变性和脂肪变性(P<0.01)。结论: 水飞蓟素阻止大鼠酒精性脂肪肝形成,其作用机制包括:抗氧化、清除自由基代谢产物,抑制脂质过氧化反应;调血脂、减少脂肪在肝脏的沉积;抗免疫性炎症和抗增殖。

关 键 词:水飞蓟宾  酒精性脂肪肝  自由基损伤  肿瘤坏死因子-α  转化生长因子-β1  
收稿时间:2004-04-21
修稿时间:2004-06-10

Effects ant mechanism of silibinin on antagonizing alcoholic fatty liver in rats
TAN Hai-Rong,WU Qian,PAN Jing-Qiang,XIAO Liu-Ying,HAN Chao,LIN Jie-Ru,ZHENG Lin-Ying,LI Bo-Ping. Effects ant mechanism of silibinin on antagonizing alcoholic fatty liver in rats[J]. Acta Metallurgica Sinica, 2004, 9(7): 803-806
Authors:TAN Hai-Rong  WU Qian  PAN Jing-Qiang  XIAO Liu-Ying  HAN Chao  LIN Jie-Ru  ZHENG Lin-Ying  LI Bo-Ping
Affiliation:Guangzhou Institute of Traditional Chinese Medicine and Materia Medica, Guangzhou 510130, Guangdong, China;1.Guangdong Provincial Institute of Materia Medica, Guangzhou 510180, Guangdong, China;2.Guangzhou Hospital of Traditional Chinese Medicine, Guangzhou 510130, Guangdong, China
Abstract:AIM: To investigate the effects and mechanism of silibinin(Sil)on rats with alcoholic fatty liver.METHODS: The animal models with alcoholic fatty liver were prepared in rats by feeding on high caloric food and drinking 10 % alcohol qd for 10 weeks ;after 6-week treatment, the effects of Sil (intragastrointestinally treated 100 mg·kg-1, qd for 4 weeks)were observed by serum activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AKP), and serum contents of total cholesterols (TC), triacylglycerol (TG), low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDL-C), tumor necrosis factor (TNF)-αand transforming growth factor (TGF)-β1, and the contents of TG, malondialdehyde (MDA), glutathione (GSH), and activity of superoxide dismutase (SOD)in the hepatic tissue.Hepatic histopathology was observed by microscope.RESULTS: Serum levels of ALT, AST and AKP decreased in administration of Sil (P<0.05 or 0.01), the levels of TG, LDL-C, TNF-αand TGF-β1 reduced (P<0.05 or 0.01), the concentrations of TG and MDA in the hepatic tissue lowered (P<0.01), and the activity of SOD potentiated (P<0.01).Hydropic and or fatty degeneration of hepatocytes were improved (P<0.01).CONCLUSION: Silibinin can preclude alcoholic fatty liver in rats from drinking alcohol and feeding high caloric food, and pharmacological mechanisms were involved in anti-oxidation and removing free radical, inhibiting lipid peroxidation, adapting blood lipid component, reducing fatty sediment in liver, anti-inflammation and anti-hyperplasia.
Keywords:silibinin  ethanolic fatty liver  free radical injure  tumor necrosis factor-α  transforming growth factor-β1  
点击此处可从《金属学报》浏览原始摘要信息
点击此处可从《金属学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号